FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On August 6, 2007
Docket # Title
1975N-0183F Topical Antimicrobial Drug Products For OTC Human Use - First Aid
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
1976N-0052N OTC Nasal Decongestants
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2005N-0272 Irradiation in the Production, Processing & Handling of Food
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2006P-0160 Change Daranide Tablets, 50 mg to a generic version
2006P-0287 Determine Whether Phoslo (calcium acetate) Tablets, eq 169 mg Calcium, have been voluntarily withdrawn from sale for safety or efficacy reasons
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006P-0399 To determine whether PhosLo (calcium acetate) Tablets, eq 169 mg calcium, and PhosLo (calcuim acetate) Capsules, eq 169 mg calcium, has been withdrawn for safety or efficacy reasons
2006P-0446 ANDA for PHENERGAN Promethazine Hydrochloride Suppositories USP, 12.5 mg and 25 mg
2007D-0083 Guidance for Industry and Food and Drug Administration Staff; Modifications to Devices Subject to Premarket Approval (PMA) Applications The PMA Supplement Decision Making Process
2007D-0125 Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
2007M-0303 P050024 - CryoCor CryoAblation System
2007N-0179 Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges; Public Workshop
2007N-0238 Medical Devices: The Mammography Quality Standards Act of 1992 and Subsequent Mammography Quality Standards Reauthorization Act and Amendments; Inspection Fees
1975N-0183F Topical Antimicrobial Drug Products For OTC Human Use - First Aid
C 23 G. Drexler Vol #: 13
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
C 94 Greg Drexler Vol #: 204
1976N-0052N OTC Nasal Decongestants
C 253 Consumer Healthcare Product Association (CHPA) Vol #: 86
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 20525 Enzmatic Vol #: 179
2005N-0272 Irradiation in the Production, Processing & Handling of Food
C 3378 V. Kreitling Vol #: 39
C 3379 M. Lambert Vol #: 39
C 3380 G. Wood Vol #: 39
C 3381 J. Reid Vol #: 39
C 3382 W. E. Baer Vol #: 39
C 3383 L. Seno Vol #: 39
C 3384 P. Bacon Vol #: 39
C 3385 D. Pinkston Vol #: 39
C 3386 T. Myers Vol #: 39
C 3387 C. Tate Vol #: 39
C 3388 L. Fahrner Vol #: 39
C 3389 M. Oyola Vol #: 39
C 3390 T. Damiano Vol #: 39
C 3391 H. Lutrin Vol #: 39
C 3392 J. Edie Vol #: 39
C 3393 N. Allison Vol #: 39
C 3394 L. Roper Vol #: 39
C 3395 D. Yutzy Vol #: 39
C 3396 L. J. Burgos Vol #: 39
C 3397 L. Lucenta Vol #: 39
C 3398 J. Gollihur Vol #: 39
C 3399 B. Fitzpatrick Vol #: 39
C 3400 C. Ring Vol #: 39
C 3401 R. Butts Vol #: 39
C 3402 L. Stone Vol #: 39
C 3403 R. Stoeckel Vol #: 39
C 3404 T. Sullivan Vol #: 39
C 3405 N. Strandt Vol #: 39
C 3406 T. Bertossi Vol #: 39
C 3407 S. Floyd Vol #: 39
C 3408 D. Herrera Vol #: 39
C 3409 P. Gaffney Vol #: 39
C 3410 D. Washington Vol #: 39
C 3411 E. Whitton Vol #: 39
C 3412 L. Kaplan Vol #: 39
C 3413 D. Pelletier Vol #: 39
C 3414 S. Fellman Vol #: 39
C 3415 A. Moriarty Vol #: 39
C 3416 V. Landis Vol #: 39
C 3417 A. Gallardo-perez Vol #: 39
C 3418 M. I. George Vol #: 39
C 3419 F. Rinella Vol #: 39
C 3420 C. Coley Vol #: 39
C 3421 J. Compere Vol #: 39
C 3422 J. Ferrante Vol #: 39
C 3423 J. And M. Stoltenberg Vol #: 39
C 3424 P. Jeden Vol #: 39
C 3425 C. Newton Vol #: 39
C 3426 R. Vanyi Vol #: 39
C 3427 S. Miller Vol #: 39
C 3428 J. I. Vincent Vol #: 39
C 3429 S. Daly Vol #: 39
C 3430 B. J. Wilcox Vol #: 39
C 3431 V. Anderson Vol #: 39
C 3432 M. Bogden Vol #: 39
C 3433 A. Shampine Vol #: 39
C 3434 J. Zoss Vol #: 39
C 3435 M. Herzog Vol #: 39
C 3436 A. Esner Vol #: 39
C 3437 B. Bowman Vol #: 39
C 3438 M. Rodriguez Vol #: 39
C 3439 S. Bayer Vol #: 39
C 3440 D. White Vol #: 39
C 3441 T. Machado Vol #: 39
C 3442 E. Wood Vol #: 39
C 3443 M. Finchum Vol #: 39
C 3444 K. Skrobiza Vol #: 39
C 3445 G. Muenzler Vol #: 39
C 3446 K. Owen Vol #: 39
C 3447 E. Shampine Vol #: 39
C 3448 V. Blessing Vol #: 39
C 3449 R. Reichel Vol #: 39
C 3450 K. Alberti Vol #: 39
C 3451 A. Saldamando Vol #: 39
C 3452 C. Price Vol #: 39
C 3453 M. Benavides Vol #: 39
C 3454 D. Mckitrick Vol #: 39
C 3455 H. Cary Vol #: 39
C 3456 Guy Boggs Vol #: 39
C 3457 G. Tucker Vol #: 39
C 3458 S. Goll Vol #: 39
C 3459 P. Ferrari Vol #: 39
C 3460 B. Swan Vol #: 39
C 3461 L. Reyes Vol #: 39
C 3462 M. Lee Vol #: 39
C 3463 J. Sieling Vol #: 39
C 3464 H. Malloy Vol #: 39
C 3465 J. Guarisco Vol #: 39
C 3466 C. D. Beardslee Vol #: 39
C 3467 S. Whalen Vol #: 39
C 3468 M. Pinckert Vol #: 39
C 3469 R. A. Main Vol #: 39
C 3470 B. Fritz Vol #: 39
C 3471 L. K. Beard Vol #: 39
C 3472 M. F. Krupa Vol #: 39
C 3473 I. Mele Vol #: 39
C 3474 W. Stremic Vol #: 39
C 3475 S. Omalley Vol #: 39
C 3476 P. Mcarthur Vol #: 39
C 3477 M. Alford Vol #: 39
C 3478 C. Jenkins Vol #: 39
C 3479 C. Roell Vol #: 39
C 3480 D. Ream Vol #: 39
C 3481 B. Schanding Vol #: 39
C 3482 H. Jackson Vol #: 39
C 3483 R. Condict Vol #: 39
C 3484 S. Pullen Vol #: 39
C 3485 V. Seeley Vol #: 39
C 3486 M. Rick Vol #: 39
C 3487 K. J. Townsend Vol #: 39
C 3488 B. Dirosse Vol #: 39
C 3489 K. Marohn Vol #: 39
C 3490 D. Maurer Vol #: 39
C 3491 J. Orr Vol #: 39
C 3492 M. Mutch Vol #: 39
C 3493 J. Andrzejewski Vol #: 39
C 3494 M. Harrison Vol #: 39
C 3495 K. Ward Vol #: 39
C 3496 D. Gatlin Vol #: 39
C 3497 L. C. Granger Vol #: 39
C 3498 L. Reuther Vol #: 39
C 3499 J. O'connor Vol #: 39
C 3500 M. Cremer Vol #: 39
C 3501 P. Joshi Vol #: 39
C 3502 H. Porter Vol #: 39
C 3503 V. Myers Vol #: 39
C 3504 J. Czubati Vol #: 39
C 3505 Rev. T. Brown Vol #: 39
C 3506 B. Jefferies Vol #: 39
C 3507 M. Maginel Vol #: 39
C 3508 M. Lewis Vol #: 39
C 3509 R. Hosek Vol #: 39
C 3510 R. A. Roth Vol #: 39
C 3511 S. L. Johnston Vol #: 39
C 3512 N. Bettinger Vol #: 39
C 3513 C. Snively Vol #: 39
C 3514 R. Stuart Vol #: 39
C 3515 R. Martinez Vol #: 39
C 3516 R. Young Vol #: 39
C 3517 A. Jones Vol #: 39
C 3518 S. Eames Vol #: 39
C 3519 D. Waters Vol #: 39
C 3520 J. Limbach Vol #: 39
C 3521 D. Mendall Vol #: 39
C 3522 D. Tickner Vol #: 40
C 3523 Y. Quimby Vol #: 40
C 3524 F. Greenlee Vol #: 40
C 3525 P. Houseweart Vol #: 40
C 3526 C. Timo Vol #: 40
C 3527 K. Waxler Vol #: 40
C 3528 P. Robertson Vol #: 40
C 3529 K. Mclaren Vol #: 40
C 3530 J. Bryan Vol #: 40
C 3531 Bernadette Wesolowski Vol #: 40
C 3532 T. Jeffries Vol #: 40
C 3533 B. Norwood Vol #: 40
C 3534 C. Barrett Vol #: 40
C 3535 F. Powers Vol #: 40
C 3536 G. Beals Vol #: 40
C 3537 L. Brent Vol #: 40
C 3538 G. Thomas Vol #: 40
C 3539 P. Corral Vol #: 40
C 3540 F. Scheffel Vol #: 40
C 3541 K. Nadasky Vol #: 40
C 3542 J. Eisenstein Vol #: 40
C 3543 R. Wright Vol #: 40
C 3544 D. Marvel Vol #: 40
C 3545 M. Larson Vol #: 40
C 3546 P. Kurth Vol #: 40
C 3547 T. Wampler Vol #: 40
C 3548 G. Brandt Vol #: 40
C 3549 J. Lafleur Vol #: 40
C 3550 B. Wilson Vol #: 40
C 3551 S. Trumbo Vol #: 40
C 3552 S. Herbert Vol #: 40
C 3553 M. Monteleon Vol #: 40
C 3554 D. Gilliam Vol #: 40
C 3555 E. Oberweiser Vol #: 40
C 3556 K. Honeycutt Vol #: 40
C 3557 H. Pitre Vol #: 40
C 3558 J. E. Farrell Vol #: 40
C 3559 A. M. Skinner Vol #: 40
C 3560 D. Clore Vol #: 40
C 3561 D. Weinischke Vol #: 40
C 3562 K. Sturtz Vol #: 40
C 3563 M. Beaudin Vol #: 40
C 3564 T. Lauro Vol #: 40
C 3565 B. Crowley Vol #: 40
C 3566 C. Morris Vol #: 40
C 3567 S. Marshall Vol #: 40
C 3568 G. Walker Vol #: 40
C 3569 M. Thrantell Vol #: 40
C 3570 E. Mcnamee Vol #: 40
C 3571 R. Criner Vol #: 40
C 3572 M. Mckay Vol #: 40
C 3573 J. Davis Vol #: 40
C 3574 M. Potkin Vol #: 40
C 3575 E. Arena Vol #: 40
C 3576 J. Matthews Vol #: 40
C 3577 C. Gates Vol #: 40
C 3578 C. Behrendt Vol #: 40
C 3579 A. Drager Vol #: 40
C 3580 S. Hong Vol #: 40
C 3581 B. Batcheldor Vol #: 40
C 3582 B. Deckard Vol #: 40
C 3583 S. and A. Osborn Vol #: 40
C 3584 K. Pettit Vol #: 40
C 3585 W. Schmidt Vol #: 40
C 3586 R. Gingerich Vol #: 40
C 3587 G. Vince Vol #: 40
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 105 W. & R. McKinstry Vol #: 2
C 106 B. Freitag Vol #: 2
C 107 R. Small Vol #: 2
C 108 D. Silver Vol #: 2
C 109 R. Droz Vol #: 2
C 110 P. Averill Vol #: 2
C 111 A. Torre Vol #: 2
C 112 R. Kantrowitz Vol #: 2
C 113 L. Monzo Vol #: 2
C 114 A. Papp Vol #: 2
C 115 A. Fussell Vol #: 2
C 116 T. Nikolits Vol #: 2
C 117 D. Frye Vol #: 2
C 118 B. Schultz Vol #: 2
C 119 E. Avers Vol #: 2
C 120 J. Brenner Vol #: 2
C 121 V. Lazar Vol #: 2
C 122 S. Chan Vol #: 2
C 123 K. Ogborn Vol #: 2
C 124 S. Torimino Vol #: 2
C 125 K. Kelly Vol #: 2
C 126 J. Simmons Vol #: 2
C 127 D. Kominsky Vol #: 2
C 128 J. Gogan Vol #: 2
C 129 M. Avila Vol #: 2
C 130 C. Zajackowski Vol #: 2
C 131 G. King Vol #: 2
C 132 S. Dyson Vol #: 2
C 133 D. Cortese Vol #: 2
C 134 J.Malone Vol #: 2
C 135 L. Muller Vol #: 2
C 136 D. Leister Vol #: 2
C 137 S. Levy Vol #: 2
C 138 M. Ayers-Cumbow Vol #: 2
C 139 D. Wenclewicz Vol #: 2
C 140 S. Mann Vol #: 2
C 141 R. Austin Vol #: 2
C 142 N. Gamlam Vol #: 2
C 143 B. Shaw Vol #: 2
C 144 J. Hayes Vol #: 2
C 145 C.Hudson Vol #: 2
C 146 K. Hisey Vol #: 2
C 147 M. Potvin Vol #: 2
C 148 J. Hogan Vol #: 2
C 149 B. Friedman Vol #: 2
C 150 P. George Vol #: 2
C 151 L. Goo Vol #: 2
C 152 N. Lloyd Vol #: 2
C 153 C. Moccia Vol #: 2
C 154 J. Thomasson Vol #: 2
C 155 M. Picoult Vol #: 2
C 156 S. Finocchiaro Vol #: 2
C 157 F. Stowman Vol #: 2
C 158 K. Ryzewski Vol #: 2
C 159 T. Wright Vol #: 2
C 160 C. Cron Vol #: 2
C 161 S. Wilson Vol #: 2
C 162 M. King Vol #: 2
C 163 E. LaMore Vol #: 2
C 164 R. Poletti Vol #: 2
C 165 D. Gussert Vol #: 2
C 166 William Storms Allergy Clinic Vol #: 2
C 167 M. Kaliner Vol #: 2
C 168 H. Hough Vol #: 3
C 169 W. Lilley Vol #: 3
C 170 E. Chandler Vol #: 3
C 171 L. Bozman Vol #: 3
C 172 w. Holton Vol #: 3
C 173 M. Balavender Vol #: 3
C 174 B. Robinson Vol #: 3
C 175 J. Bogle Vol #: 3
C 176 K. Groh Vol #: 3
C 177 L. Yob Vol #: 3
C 178 J. Henthorn Vol #: 3
C 179 P. McDougall Vol #: 3
C 180 R. Hoke Vol #: 3
C 181 M. Kurkowski Vol #: 3
C 182 E. Cipriani Vol #: 3
C 183 D. Causer Vol #: 3
C 184 S. Chiodo Vol #: 3
C 185 M. Wintter Vol #: 3
C 186 N. Dowd Vol #: 3
C 187 J. Flaherty Vol #: 3
C 188 J. Kish Vol #: 3
C 189 R. Latham Vol #: 3
C 190 C. Silver Vol #: 3
C 191 V. Focosi Vol #: 3
C 192 J. Geoffrion Vol #: 3
C 193 K. Johnston Vol #: 3
C 194 J. Pinto Vol #: 3
C 195 C. Parks Vol #: 3
C 196 W. Hyde Vol #: 3
C 197 J. Hengesbach Vol #: 3
C 198 D. Morse Vol #: 3
C 199 E. Maniaci Vol #: 3
C 200 A. Cunningham Vol #: 3
C 201 H. Szcyurek Vol #: 3
C 202 D. Osman Vol #: 3
C 203 E. Huber Vol #: 3
C 204 C. Browning Vol #: 3
C 205 R. Rosenberg Vol #: 3
C 206 L. Pang Vol #: 3
C 207 L. Spychalski Vol #: 3
C 208 E. Warrick Vol #: 3
C 209 R. Payton Vol #: 3
C 210 W. Hunt Vol #: 3
C 211 H. Morton Vol #: 3
C 212 T. Vogt Vol #: 3
C 213 G. McMillan Vol #: 3
C 214 J. Thacher Vol #: 3
C 215 I. Collazo Vol #: 3
2006P-0160 Change Daranide Tablets, 50 mg to a generic version
N 1 FDA Vol #: 1
2006P-0287 Determine Whether Phoslo (calcium acetate) Tablets, eq 169 mg Calcium, have been voluntarily withdrawn from sale for safety or efficacy reasons
N 1 FDA Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
C 126 J. Davenport Vol #: 7
C 127 A. Arbogast Vol #: 7
2006P-0399 To determine whether PhosLo (calcium acetate) Tablets, eq 169 mg calcium, and PhosLo (calcuim acetate) Capsules, eq 169 mg calcium, has been withdrawn for safety or efficacy reasons
N 1 FDA Vol #: 1
2006P-0446 ANDA for PHENERGAN Promethazine Hydrochloride Suppositories USP, 12.5 mg and 25 mg
N 1 FDA Vol #: 1
2007D-0083 Guidance for Industry and Food and Drug Administration Staff; Modifications to Devices Subject to Premarket Approval (PMA) Applications The PMA Supplement Decision Making Process
C 5 Advance Medical Technology Association (AdvaMed) Vol #: 1
2007D-0125 Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims
C 1 J. Slama Vol #: 1
EXT 1 A. Young Vol #: 1
2007M-0303 P050024 - CryoCor CryoAblation System
AAV 1 CryoCor, Inc. Vol #: 1
2007N-0179 Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges; Public Workshop
TS 3 HHS/AHRQ Vol #: 2
TS 4 FDA Vol #: 2
TS 5 University of Pennsylvania Vol #: 2
TS 6 FDA Vol #: 2
TS 7 Fairfield County MM Support Group Vol #: 2
TS 8 MS Internet Support Forum Vol #: 2
TS 9 Blue Cross and Blue Shield Vol #: 2
TS 10 Blue Cross and Blue Shield Vol #: 2
TS 11 Kaiser Permanente Vol #: 2
TS 12 Veteran's Administration Vol #: 2
TS 13 American Academy of Family Physicians Vol #: 2
TS 14 Celgene Corporation Vol #: 2
TS 15 Biogen Idec, Inc. Vol #: 2
TS 16 AHRQ/FDA Vol #: 2
TS 17 Duke Center for Education and Research on Therapeutics Vol #: 2
TS 18 University of Pennsylvania Vol #: 2
TS 19 FDA Vol #: 2
TS 20 University of Arizona Vol #: 2
TS 21 HMO Research Network CERT Vol #: 2
TS 22 FDA Vol #: 2
TS 23 National Steering Committee CERT Vol #: 2
TS 24 National Steering Committee CERT Vol #: 2
TS 25 Outcome Sciences Vol #: 2
TS 26 National Health Insurance in Taiwan Vol #: 2
TS 27 Johnson & Johnson Vol #: 2
TS 28 American Foundation for Material and Child Health Vol #: 1
2007N-0238 Medical Devices: The Mammography Quality Standards Act of 1992 and Subsequent Mammography Quality Standards Reauthorization Act and Amendments; Inspection Fees
BKG 1 Background Material Vol #: 1

Page created on August 7, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management